Intended Use

Ceevra Reveal 3+ is intended as a medical imaging system that allows processing, review, analysis, communication, and media interchange of multi-dimensional digital images from CT or MR imaging devices, including generating preliminary segmentations of normal anatomy using machine learning and computer vision algorithms. It is also for preoperative surgical planning and intraoperative display, assisting clinicians in patient management decisions.

Technology

Ceevra Reveal 3+ is a software as a medical device that transforms CT and MR images into interactive 3D visualizations for preoperative and intraoperative use. It uses machine learning and computer vision algorithms to generate semi-automated segmentations of normal anatomy such as pulmonary arteries, veins, airways, and bronchopulmonary segments. Clinicians can interact via mobile or desktop applications with capabilities for rotation, zoom, measurements, and selective anatomy display.

Performance

The software validation included verification on 133 independent CT and MR imaging studies ensuring demographic and scanner diversity. Four machine learning models segment various structures (prostate, bladder, kidney, pulmonary arteries and veins, airways, bronchopulmonary segments) with Dice scores ranging from 0.82 to 0.93. Measurement features were validated on phantom and clinical imaging studies.

Predicate Devices

No predicate devices specified

Device Timeline

  • 1

    Submission

    12/20/2024

    2 months
  • 2

    FDA Approval

    3/4/2025

Other devices from Ceevra, Inc.

Ready to Sharpen Your Edge?

Join hundreds of your peers who rely on RadAI Slice. Get the essential weekly briefing that empowers you to navigate the future of radiology.

We respect your privacy. Unsubscribe at any time.